Key result
Current literature reveals a significant absence of randomized controlled trials to guide the interventional and medical management of spontaneous coronary artery dissection.
Why the study?
There is a lack of reported literature, understanding, and randomized controlled trials to guide short- and long-term medical and interventional management for spontaneous coronary artery dissection.
This review highlights the current lack of randomized controlled trials and evidence-based guidelines for the optimal short- and long-term management of spontaneous coronary artery dissection.
Answers are grounded in this paper and cite their sources.
SCAD management lacks evidence-based guidance; leaves open the need for prospective trials to define optimal strategies in affected women.
Though an infrequent cause of acute coronary syndrome, spontaneous coronary artery dissection is an increasingly recognized cardiovascular condition predominantly seen in middle-aged females. Its pathophysiology is defined by separation of coronary arterial wall layers which cause acute coronary syndrome-like presentations with relatively high recurrence rates. Overall, there is a lack of reported literature and understanding of the short- and long-term management for spontaneous coronary artery dissection. Therapeutic approaches include, but are not limited to, percutaneous coronary intervention, surgical revascularization, antithrombotic therapy, and beta-blocker therapy. There is a significant absence of randomized control trials to help guide both interventional and medical management for spontaneous coronary artery dissection. This review is aimed to review the current literature regarding risk factors and considerations for the short- and long-term management of spontaneous coronary artery dissection.
No takes yet. Share an insight, caveat, or question.
Patail et al. (2023) conducted a review in Spontaneous coronary artery dissection. Management strategies (percutaneous coronary intervention, surgical revascularization, antithrombotic therapy, beta-blocker therapy) was evaluated. Current literature reveals a significant absence of randomized controlled trials to guide the interventional and medical management of spontaneous coronary artery dissection.
Synapse has enriched 10 related papers. Consider them for comparative context: